Submitted Successfully!
To reward your contribution, here is a gift for you: A free trial for our video production service.
Thank you for your contribution! You can also upload a video entry or images related to this topic.
Version Summary Created by Modification Content Size Created at Operation
1
Kayanush Aryana
 -- 3274 2022-12-20 22:26:40 |
2 format correct
Catherine Yang
 -26 word(s) 3248 2022-12-21 03:27:42 |

Video Upload Options

We provide professional Video Production Services to translate complex research into visually appealing presentations. Would you like to try it?
No, upload directly Yes

Confirm

Are you sure to Delete?
Yes No
Cite
If you have any further questions, please contact Encyclopedia Editorial Office.
Olson, D.W.;  Aryana, K.J. Yogurt with Incorporated Probiotics. Encyclopedia. Available online: https://encyclopedia.pub/entry/39005 (accessed on 18 November 2024).
Olson DW,  Aryana KJ. Yogurt with Incorporated Probiotics. Encyclopedia. Available at: https://encyclopedia.pub/entry/39005. Accessed November 18, 2024.
Olson, Douglas W., Kayanush J. Aryana. "Yogurt with Incorporated Probiotics" Encyclopedia, https://encyclopedia.pub/entry/39005 (accessed November 18, 2024).
Olson, D.W., & Aryana, K.J. (2022, December 20). Yogurt with Incorporated Probiotics. In Encyclopedia. https://encyclopedia.pub/entry/39005
Olson, Douglas W. and Kayanush J. Aryana. "Yogurt with Incorporated Probiotics." Encyclopedia. Web. 20 December, 2022.
Yogurt with Incorporated Probiotics
Edit
This entry is adapted from the peer-reviewed paper 10.3390/app122412607

Probiotics are commonly added to yogurt to provide many health benefits for the consumer. A description is provided for some commonly used probiotics in yogurt. A GRAS (generally recognized as safe) list of probiotic bacteria that can be added to yogurt or similar types of products is provided. Additionally, prebiotics, synbiotics (combination of prebiotics and probiotics), postbiotics, paraprobiotics, and psychobiotics can be added to yogurt. Probiotic yogurt can come in various forms in addition to spoonable yogurt, and yogurt can be used as an ingredient in other food products. Many useful functional ingredients can be applied to probiotic yogurt. The safety of probiotics must be addressed, especially for critically ill patients and other susceptible populations.

probiotic fermented yogurt health

1. History of Discovery and Definitions of Probiotics

Experiments for studying effects of bacteria on treating health problems and promoting good health have been performed for a long time. Theodor Escherich has been credited as the first pediatric infectious disease physician and described Bacterium coli commune (now referred to as Escherichia coli) in 1886 [1]. While working under Theodor Escherich, Dr. Józef Brudziński treated infants for acute infectious diarrhea by using a Bacillus lactis aërogenes suspension described in publications from 1899 [2][3]. Although Élie Metchnikoff [4] believed that intestinal putrefaction can shorten life, he noted the work of Dr. Brudziński and similar work by Dr. Henry Tissier and recommended people “to absorb large quantities of microbes”. He believed that lactic bacteria can fight against intestinal putrefaction. He also wrote that Stamen Grigoroff observed many centenarians in Bulgaria, which is a region where yahourth (yogurt) was commonly consumed [4]. The fact that diet affects the types of bacteria that develops within the intestinal tract was first clearly established by Herter and Kendall in 1910, but suggested as early as 1886 by Escherich and Hirschler [5].
Many of the starter cultures and probiotics now used in yogurt making were first described in the late 1800s or early 1900s. The name “Streptococcos” was first used in 1874 by Albert Theodor Billroth [6]. Streptococcus thermophilus (later reclassified as Streptococcus salivarius subsp. thermophilus by Farrow and Collins in 1984 [7] but revived back to Streptococcus thermophilus by Schleifer et al. in 1991 [8]) was described by S. Orla-Jensen in 1919 [9]. In 1901, Martinus Beijerinck proposed the genus Lactobacillus to include Gram-positive, fermentative, facultatively anaerobic, non-sporeforming bacteria [10]. Stamen Grigoroff discovered Bulgarian bacillus (now Lactobacillus delbrueckii ssp. bulgaricus) in 1905 [11]. Lactobacillus acidophilus (originally called Bacillus acidophilus) was described by Ernst Moro in 1900 [12]. In 1899 and 1900, Henry Tissier first described Bacillus bifidus communis, later referred to as Lactobacillus bifidus and now referred to as Bifidobacterium [13]. He found that Bifidobacteria was the main type of bacteria comprising the gut microflora of breast-fed babies and Bifidobacteria could treat acute gastroenteritis [11].
Dr. Isaac Carosso recommended to his patients who suffered from gastrointestinal problems to consume yogurt. Afterwards, he started producing yogurt and founded the Danone Company in 1919 [11].
The term “probiotic” (meaning “for life”) originated in 1953 from Werner Kollath to mean “active substances that are essential for a healthy development of life” [14]. Lilly and Stillwell [15] used the term probiotic as “substances secreted by one organism which stimulate the growth of another” in 1965. Parker [16] described probiotics as “organisms and substances which contribute to intestinal microbial balance” in 1974. Fuller [17] defined probiotics as “A live microbial feed supplement which beneficially affects the host animal by improving its intestinal microbial balance” in 1989. A panel from the International Scientific Association for Probiotics and Prebiotics defined probiotic as “live microorganisms that, when administered in adequate amounts, confer a health benefit on the host” in 2014 [18].

2. Gut Microbiome, Inflammation, and Health Benefits Provided by Probiotics

The human gut microbiome (also known as microbiota or microflora) consists of bacteria (predominantly obligate anaerobes), archaea, fungi, and protists and functions by metabolizing nutrients (by converting indigestible carbohydrates into short-chain fatty acids) for the host, maintaining the gut mucosal barrier, modifying the immune system, inhibiting pathogens, and even affecting brain activities. Most of these bacteria belong to the Firmicutes and Bacteroidetes phyla with fewer bacteria belonging to Actinobacteria, Proteobacteria, Fusobacteria, and Verrucomicrobia phyla. Firmicutes bacteria are Gram-positive and are involved in short chain fatty acid synthesis and in hunger and satiety regulation [19]. Bacteroidetes bacteria are Gram-negative and are involved with enhancing immune reactions and inflammation. A loss of a balanced ratio between Firmicutes and Bacteroidetes leads to dysbiosis (lack of normal intestinal homeostasis), obesity (increased Firmicutes to Bacteroidetes ratio), inflammatory bowel disease (decreased Firmicutes to Bacteroidetes ratio), and other diseases [19]. The Firmicutes phylum includes Clostridium (95% of this phylum), Lactobacillus, Bacillus, Enterococcus, and Ruminicoccus genera, and the Bacteroidetes phylum consists of Bacteroides and Prevotella genera [20]. Although early studies estimated the microorganism population as more than 100 trillion and number of human cells as around 10 trillion, more recent estimates state a ratio of 1.3 bacteria cells to each human cell [21]. The microbiome produces a wide variety of metabolites and can account for some of the variation in plasma metabolites between individuals [22]. The composition of the gut microbiome and gut-derived metabolites are associated with the occurrence of a wide variety of chronic diseases [23]. In addition, the effect that diet and exercise have on cognition is affected by the gut microbiome [24]. Furthermore, the microbiota was found to affect social behavior in zebrafish during early neurodevelopment [25]. However, the gut microflora can be affected by various factors including consumption of fermented dairy products [26][27][28].
While acute (high-grade but short-term) inflammation is needed for healing, trigger removal, and tissue repair, systemic chronic (low-grade but persistent) inflammation can lead to a wide variety of adverse health conditions including metabolic syndrome (hypertension, hyperglycemia, and dyslipidemia), type 2 diabetes, nonalcoholic fatty liver disease, cardiovascular disease, chronic kidney disease, multiple cancer types, depression, neurodegenerative and autoimmune diseases, osteoporosis, and sarcopenia [29]. Probiotics, along with prebiotics, resistant starch, and resistant proteins, can decrease chronic low-grade inflammation by producing short-chain fatty acids (acetate, propionate, and butyrate), improving phagocytic activity, and reducing pro-inflammatory cytokine production to potentially promote healthy aging [30].
Probiotics provide many health benefits. Some of these health benefits provided by probiotics, postbiotics, and paraprobiotics (to be discussed later) with either mixed or strong evidence for effectiveness in clinical trials are summarized in Table 1 [31][32][33][34][35][36][37][38][39][40][41][42][43][44][45][46][47][48][49][50][51][52][53][54][55][56][57][58][59][60][61][62][63][64][65][66][67][68][69][70][71][72][73][74][75][76][77][78][79][80][81][82][83][84][85][86][87][88][89][90][91][92][93][94][95][96][97][98][99][100][101][102][103][104][105][106][107][108][109][110][111][112][113][114][115][116][117][118][119][120][121][122][123][124][125][126][127][128][129][130][131]. Because of the complexity involved in being consistent when evaluating the strength of the evidence for the effectiveness of probiotics in preventing or treating each of these adverse health conditions or providing the health benefits, no attempt was made for this evaluation. The efficacy of probiotics in controlling Crohn’s disease usually could not be shown [132]. More details about the health benefits provided by yogurt and probiotic fermented milks are provided by Sakandar and Zhang [133], and Hadjimbei et al. [134].
Table 1. Some health benefits for which probiotics, postbiotics, and paraprobiotics have shown a mixed to favorable result in an original study or in a meta-analysis. Due to the difficulty of being consistent involved in evaluating the strength of the evidence for the effectiveness of probiotics in preventing or treating each of these health conditions, no attempt was made for the evaluation of effectiveness for the probiotics listed in this table.
Health Condition Probiotic Original Article or Review Paper Reference
Periodontal disease   Review [31]
Bacterial tonsillitis Streptococcus salivarius BIO5 Original [135]
Anti-inflammatory and antibiofilm activities against oral pathogens Enterococcus faecalis M157 in fermented whey Original [32]
Lactose intolerance   Review [33]
Galactosemia Galactose positive S. thermophilus NCDC 659 (AJM), 660 (JMI), and 661 (KM3) Original [34]
Short-chain fatty acid production VSL#3 1 Original [35]
Vitamin production   Review [36]
Gamma-aminobutyric acid production L. plantarum K16 Original [37]
Protection against foodborne illness   Review [38]
Colonization of Campylobacter L. plantarum LPS Original [39]
Anti-listerial activity Postbiotics of L. acidophilus LA5, L. casei 431, and L. salivarius Ls-BU2 Original [40]
Antimicrobial therapy   Review [41]
Gut microbiome development in very preterm infants Either B. bifidum and L. acidophilus or B. bifidum and B. longum subsp. infantis and L. acidophilus Original [42]
Healthy microbiome B. subtilis DE111 Original [43]
Restoration of microbiome after antibiotic treatment L. acidophilus and B. bifidum Original [44]
Improve microbiome in cirrhosis patients Multispecies probiotics Original [45]
Modulate gut microbiota and reduce exposure to uremic toxins in hemodialysis patients Bifico (B. longum NQ1501, L. acidophilus YIT2004, and E. faecalis YIT0072) Original [46]
Gut bacterial diversity Bacillus coagulans GBI-30 6086 Original [47]
Leaky gut Probiotic cocktail of 5 Lactobacilli and 5 Enterococci strains Original [48]
Improve Gut Epithelial Barrier S. thermophilus BGKMJ1-36 and L. bulgaricus BGVLJ1-21 Original [49]
Antioxidative activity   Review [50]
Antioxidant activity and intestinal permeability in cancer carcinogenesis VSL#3 1 Original [51]
Oxidative and inflammatory stress reduction L. plantarum S1 (viable and heat-killed cells and metabolites) from fermented whey Original [52]
Immunity   Review [53]
Exopolysaccharide production for immunomodulatory, antimicrobial, antioxidant, and anticancer activities Lactobacillus Review [54]
Highly symptomatic celiac disease Bifidobacterium infantis NLS super strain Original [55]
Viral infections Various probiotics and paraprobiotics Review [56]
Possible inhibition of HIV transmission and replication Engineered L. rhamnosus GG and GR-1 Original [57]
Diarrhea in HIV/AIDS patients Probiotic yogurt with L. rhamnosus GR-1 and L. reuteri RC-14 Original [58]
Antibiotic-associated diarrhea B. animalis subsp. lactis XLTG11 Original [59]
Chemotherapy-induced diarrhea in lung cancer patients Clostridium butyricum Original [60]
Enteral-tube-feeding diarrhea 2   Review [61]
Childhood rotavirus infections   Review [62]
Acute pediatric diarrhea   Review [63]
Travelers diarrhea Lactobacillus GG Original [64]
  L. acidophilus and B. bifidum Original [65]
Clostridioides difficile diarrhea L. rhamnosus GG Original [66]
Helicobacter pylori infection Limosilactobacillus fermentum UCO-979C Original [67]
Constipation L. acidophilus LA11-Onlly, L. rhamnosus LR22, L. reuteri LE16, L. plantarum LP-Onlly, and B. animalis subsp. lactis BI516 Original [68]
  L. rhamnosus LR-168, L. acidophilus LA-99, and B. animalis BB-115 Original [69]
Irritable bowel syndrome   Review [70]
Necrotizing enterocolitis B. longum subsp. infantis Original [71]
Ulcerative colitis   Review [72]
    Review [73]
Hospital stay for acute pancreatitis   Review [74]
Colorectal cancer   Review [75]
Gastrointestinal cancer   Review [76]
Liver and breast cancer Streptococcus salivarius BP8, BP156, and BP160 Original [77]
Breast cancer   Review [78][79]
Prostate cancer Whey beverages with L. acidophilus La-05, L. acidophilus La-03, L. casei-01, and B. animalis Bb-12 Original [80]
Cervical cancer   Review [81]
Polycystic ovary syndrome   Review [82]
Vaginosis Lactobacillus Original [83]
Antimicrobial activity (hydrogen peroxide, bacteriocins, and lactic acid production) for vaginal health Lactobacillus crispatus Review [84]
Inhibit sperm activity Lactobacillus crispatus Original [85]
Male fertility disorders   Review [86]
Bladder cancer   Review [87]
Bladder diseases (bladder cancer, interstitial cystitis, and overactive bladder)   Review [88]
Reduce exposure to uremic toxins in hemodialysis patients Bifico (B. longum NQ1501, L. acidophilus YIT2004, and E. faecalis YIT0072) Original [46]
Pediatric urinary tract infection recurrence L. acidophilus, L. rhamnosus, B. bifidum, and B. lactis Original [89]
Urinary excretion of oxalate (risk factor for renal stones) L. acidophilus, L. brevis, L. plantarum, B. infantis, and S. thermophilus Original [90]
Idiopathic nephrotic syndrome Clostridium butyricum Original [91]
Lung metastasis of melanoma cells VSL#3 1 Original [35]
Respiratory tract infection   Review [92]
Influenza A virus L. mucosae 1025 and B. breve CCFM1026 Original [93]
COVID-19 Probiotics and their metabolites Review [94]
Ventilator-associated pneumonia in critically ill patients   Review [95]
Allergic rhinitis Bifidobacterium mixture Review [96]
Respiratory allergy Commercial probiotic fermented milk Original [97]
Asthma L. paracasei K47 Original [98]
Cystic fibrosis   Review [99]
Atopic dermatitis   Review [100]
Skin disorders (atopic dermatitis, psoriasis, rosacea, and acne vulgaris)   Review [101]
Skin health L. reuteri ATCC 6475 Original [102]
Dry eye L. plantarum NK151 and B. bifidum NK175 Original [103]
Vernal keratoconjunctivitis L. acidophilus eye drops Original [104]
Rheumatoid arthritis 2   Review [105][106]
Recovery from bone fractures L. casei Shirota Original [107]
Pain relief after rib fracture L. casei Shirota Original [108]
Mineral absorption and bone health L. rhamnosus HN001 Original [109]
Calcium absorption L. rhamnosus GG * Original [110]
Iron absorption   Review [111]
Blood lipids B. subtilis DE111   [112]
Fasting glucose and insulin levels   Review [113]
Diabetes (blood pressure, fasting blood sugar, cholesterol, triglyceride, hemoglobin A1c, high sensitive C-reactive protein) Probiotic yogurt Original [114]
Serum triglyceride and glucose Bacillus coagulans GBI-30 6086 Original [47]
Atherosclerosis (lesion formation, dyslipidemia, endothelial dysfunction, inflammation, hypertension and hyperglycemia, and TMAO (trimethylamine N-oxide))   Review [115]
Infantile colic B. breve CECT7263 Original [116]
Obesity L. reuteri ATCC 6475 Original [117]
    Review [118]
Liver fibrosis L. paracasei, L. casei, and Weissella confusa Original [119]
Non-alcoholic fatty liver disease   Review [120]
Hyperuricemia   Review [121]
Phenylketonuria Genetically engineered probiotics Review [122]
Exercise performance and decrease fatigue L. salivarius subsp. salicinius SA-03 Original [123]
Sleep   Review [124]
Depression and anxiety   Review [125]
Anxiety   Original [126]
Serotonin biosynthesis from tryptophan L. plantarum LRCC5314 Original [127]
Mood   Original [128]
Memory and learning L. paracasei ssp. paracasei BCRC 12188, L. plantarum BCRC 12251, and S. thermophilus BCRC 13869 Original [129]
Age related dementia   Review [130]
Autism   Review [131]
1 VSL#3 includes B. breve, B. infantis, B. longum, L. acidophilus, L. bulgaricus, L. casei, L. plantarum, and S. thermophilus. 2 Mixed results. * Inulin was also included in the treatment which may have contributed to the favorable results.
Different strains of bacteria provide their health benefits by different mechanisms [136], and knowledge of these mechanisms can help in probiotic selection and modification for effectively treating disease. Four main mechanisms by which probiotics confer health benefits include potential pathogen interference, barrier function improvement, immunomodulation, and neurotransmitter production [137]. Pathogen interference mechanisms include production of antimicrobial compounds including bacteriocins and defensins, competition with pathogens, inhibition of adherence of pathogens, and luminal pH reduction [136]. Probiotics such as L. rhamnosus can be bioengineered for an alternative method for pathogen inhibition within the field known as pathobiotechnology [138].
Gut microbiomes vary from person to person [20]. Individuals vary in the ability of which consumed probiotics, such as in a fermented milk product, are able to modify the composition of the autochthonous gut microflora, suggesting that a tailored diet may be needed for individuals that are on a beneficial microbial based therapy and have a resistant gut microbiota [139]. Veiga et al. [140] predicts that many people will have their genome sequenced in the future that will allow them to tailor specific probiotics (referred to as precision probiotics) to their unique human-microbiome symbiosis to optimize their microbiome-centered nutrition and preventative health care. Perhaps in the future, yogurt could be a carrier for these precision probiotics.

3. Use of Probiotic Yogurt as an Ingredient

Probiotic yogurt can be used as an ingredient in the production of other products. Bite sized refrigerated yogurt that can be eaten using fingers can be prepared by coating frozen yogurt portions (possibly containing probiotics) with two layers of fat-based coating [141]. The second layer of this fat coating is applied before allowing the frozen yogurt to thaw, and this second layer may contain particulate inclusions [141]. A snack bar coated with a yogurt containing probiotics (L. acidophilus or B. lactis or both) and incorporating waxy grains held together by an inulin binder has been patented [142]. A shelf-stable fruit snack that contains an outer layer that could consist of yogurt containing probiotic cultures has been patented [143]. Gutknecht and Ovitt [144] patented low-fat yogurt cheese consisting of 15% to 75% cream cheese, 10% to 40% yogurt incorporating L. acidophilus, Bifidobacterium, or L. paracasei subsp. casei in addition to yogurt starter cultures, and 15% to 45% milk protein. Freeze dried yogurt that may contain probiotic cultures is an ingredient in a dry mix food product that also contains other food ingredients (whole grain, fruits, nuts, granola, etc.), and this dry mix can be hydrated to form a thick texture similar to yogurt within 3 min [145]. A shelf-stable light and crunchy yogurt crisp, a snack food, is made from a viscoelastic dough that contains dehydrated yogurt and may contain probiotics, either in the spore form or microencapsulated form [146].

4. Useful Functional Ingredients in Probiotic Yogurt

Many ingredients have successfully been added to probiotic yogurt. Some of these useful functional ingredients are listed in Table 2. These functional ingredients include grains, seeds, flours, fibers, fruits, vegetables, a berry, a nut, juices, spices, essential oils, bee products, and a cyanobacterium.
Table 2. Some of the useful functional ingredients that have been incorporated into probiotic yogurt including their concentration and effect on the properties of the resulting yogurt.
Functional Ingredient Category and Ingredient within category. Concentration Effect on Properties Ref.
Grain, seed, and flour      
Aqueous fennel extract 2, 4, and 6% Reconstituting whole milk powder into aqueous fennel extract to manufacture probiotic yogurt resulted in a product with increased phenolic content and antioxidant activity compared to fresh yogurt. [147]
Flaxseed 0–4% Flaxseed was successfully added to yogurt containing L. acidophilus ATCC 4356. This yogurt had increased L. acidophilus counts, viscosity, hardness, cohesiveness, gumminess, and water holding capacity but decreased syneresis and adhesiveness compared to their control yogurt. [148]
Sesame seeds 6% Incorporation of roasted sesame into stirred yogurt improveds probiotic viability, sensory properties, and antioxidant properties. [149]
Psyllium husk (Native and acid-modified psyllium husk) 0.5 g per liter of buffalo milk Incorporation of psyllium husk into frozen yogurt containing the encapsulated probiotics L. acidophilus and L. plantarum formed a product with high consumer acceptability. [150]
Oat β-glucan 0.15% β-glucan and EPS-producing B. bifidum increased viscosity and water holding capacity but decreased syneresis. [151]
Wheat bran 4% Incorporation of wheat bran significantly increased total bacterial counts and titratable acidity. [152]
Resisant starch (RS2 and RS3) 1 1.5% This yogurt was made from reconstituted skim milk. RS2 increased serum held within gel network. RS3 protected B. animalis subsp. lactis BB-12, increased viscosity, and decreased titratable acidity. [153]
Chickpea flour 0, 1, 2.5, and 5% Fortification of chickpea flour into probiotic yogurt resulted in improved water holding capacity and decreased syneresis for the resulting yogurt. [154]
Fiber Ingredient      
Inulin of varying chain lengths 2 1.5% P95 lowered the pH but maintained similar flavor scores compared to the control. HP decreased syneresis and improved body and texture compared to the control. [155]
Orange fiber 0.5, 1, 1.5, and 2% Incorporating orange fiber into yogurt containing L. acidophilus LA-5 and Bifidobacterium animalis subsp. lactis BB-12 improved antioxidant activity and angiotensin converting enzyme (ACE)–inhibitory activity. [156]
Lemon and orange fibers 3 g to 200 mL The enriched fermented milk had good sensory acceptability. L. acidophilus and L. casei had better survival than B. bifidum. [157]
Wolfberry dietary fiber (goji berry) 0.5–5% Yogurt containing 2% (w/v) wolfberry dietary fiber had less syneresis, higher apparent viscosity, and increased hardness compared to control yogurt. [158]
Fruit or fruit ingredient and vegetable      
Fruit purees (peach, apple, and pear) 10 and 20% Peach and apples were the most suitable fruits for probiotic yogurt. [159]
Dragon fruit 12% The optimal formulation was 12% dragon fruit, 11% sugar, and 2% L. plantarum. Fermentation time was 19 h at 37 °C. [160]
Isabel “Precoce” grape ingredients Isabel grape preparation
(20 g/100 mL)
By-product flour
(2 g/100 mL)		 This goat milk yogurt had high L. acidophilus La-05 counts, distinct phenolic profile, higher antioxidant capacity, sensory acceptance, and consumer preference compared to control probiotic yogurt. [161]
Orange sweet potato 15 and 25% Orange sweet potato purees incorporated into probiotic yogurt were accepted by consumers. [162]
Berry and nut      
Gobdin (Dry white mulberry and walnut paste) 0, 5, and 10% Adding 5% gobdin to yogurt containing L. acidophilus resulted in an acceptable product. [163]
Juice (fruit or vegetable)      
Pomegranate juice 16% Yogurt fortified with pomegranate juice and probiotics had desirable sensory properties during storage. [164]
Carrot juice 8, 16, 24, and 32% There was increased color intensity, carrot flavor, creaminess, mouth coating, and chalkiness with increased carrot juice levels. [165]
Juice and flower      
Juice from kiwifruit and jasmine flour 20% kiwi fruit juice and 15% jasmine flower juice The best formulation was 20% kiwi fruit juice, 15% jasmine flower juice, and 5% inoculum concentration. Fermentation time was 8 h at 40 °C. [166]
Spice and Oil      
Spices (Cardamom, cinnamon, and nutmeg) 0.5% (v/w) Yogurts containing spices had good sensory properties with enhanced antioxidant activity. [167]
Ginger and chamomile essential oil 0.2 and 0.4% Ginger and chamomile essential oils and B. lactis Bb12 addition enhanced yogurt properties. Incorporation of essential oil significantly decreased fermentation time. [168]
Dill essential oil 50 and 100 ppm Yogurt containing 100 ppm dill essential oil received high sensory scores and maintained high viability of B. bifidum and L. casei. [169]
Peppermint, Basil, and Zataria essential oils 0.5% Antioxidant potential was improved by addition of all three essential oils.
Peppermint and basil yogurts had acceptable sensory properties, but zataria yogurt was not as acceptable.		 [170]
Bee products      
Pine honey 2, 4, and 6% The 2% level was the preferred level during sensory evaluation. [171]
Royal jelly 2% (w/v) Royal jelly incorporation Ssignificantly improved physicochemical, rheological, sensory, and microbiological properties (increased probiotic viability) compared to control probiotic yogurt. [172]
Cyanobacterium      
Spirulina (a biomass of cyanobacterium) 1 g per liter of yogurt mix. This yogurt was less acidic than the control yogurt on the 7th day, and there was higher growth of lactic acid bacteria in this yogurt than for the control yogurt on the 7th day. [173]
1 RS2 is high amylose corn starch while RS3 is physically modified corn starch. 2 Inulin chain lengths were short (P95), medium (GR), and long (HP).

References

  1. Shulman, S.T.; Friedmann, H.C.; Sims, R.H. Theodor Escherich: The First Pediatric Infectious Diseases Physician? Clin. Infect. Dis. 2007, 45, 1025–1029.
  2. Polaczek, P. Centenary of the Death of Józef Brudziński: On his Contribution to Early Bacteriology. Dev. Period Med. 2017, 21, 293–296.
  3. Krawczyk, R.T.; Banaszkiewicz, A. Dr. Józef Brudziński—The True ‘Father of Probiotics’. Benef. Microbes 2021, 12, 211–213.
  4. Metchnikoff, E. The Prolongation of Life; G. P. Putnam’s Sons: New York, NY, USA, 1908.
  5. Torrey, J.C. The Regulation of the Intestinal Flora of Dogs through Diet. J. Med. Res. 1919, 39, 415–447.
  6. Dapkevicius, M.; Sgardioli, B.; Câmara, S.P.A.; Poeta, P.; Malcata, F.X. Current Trends of Enterococci in Dairy Products: A Comprehensive Review of Their Multiple Roles. Foods 2021, 10, 821.
  7. Farrow, J.A.E.; Collins, M.D. DNA Base Composition, DNA-DNA Homology and Long-Chain Fatty Acid Studies on Streptococcus thermophilus and Streptococcus salivarius. J. Gen. Microbiol. 1984, 130, 357–362.
  8. Schleifer, K.H.; Ehrmann, M.; Krusch, U.; Neve, H. Revival of the Species Streptococcus thermophilus (ex Orla-Jensen, 1919) Nom. Rev. Syst. Appl. Microbiol. 1991, 14, 386–388.
  9. Orla-Jensen, S. The Lactic Acid Bacteria. In Mémoires de L’Académie Royale des Sciences et des Lettres de Danemark; Copenhague: Copenhagen, Denmark, 1919.
  10. Zheng, J.; Wittouck, S.; Salvetti, E.; Franz, C.M.A.P.; Harris, H.M.B.; Mattarelli, P.; O’Toole, P.W.; Pot, B.; Vandamme, P.; Walter, J.; et al. A Taxonomic Note on the Genus Lactobacillus: Description of 23 Novel Genera, Emended Description of the Genus Lactobacillus Beijerinck 1901, and Union of Lactobacillaceae and Leuconostocaceae. Int. J. Syst. Evol. Microbiol. 2020, 70, 2782–2858.
  11. Ozen, M.; Dinleyici, E.C. The History of Probiotics: The Untold Story. Benef. Microbes 2015, 6, 159–165.
  12. Kulp, W.L.; Rettger, L.F. Comparative Study of Lactobacillus acidophilus and Lactobacillus bulgaricus. J. Bacteriol. 1924, 9, 357–395.
  13. Poupard, J.A.; Husain, I.; Norris, R.F. Biology of the Bifidobacteria. Bacteriol. Rev. 1973, 37, 136–165.
  14. Gasbarrini, G.; Bonvicini, F.; Gramenzi, A. Probiotic History. J. Clin. Gastroenterol. 2016, 50 (Suppl. 2), S116–S119.
  15. Lilly, D.M.; Stillwell, R.H. Probiotics: Growth-Promoting Factors Produced by Microorganisms. Science 1965, 147, 747–748.
  16. Parker, R.B. Probiotics, the Other Half of the Antibiotics Story. Animal Nutr. Health 1974, 29, 4–8.
  17. Fuller, R. Probiotics in Man and Animals. J. Appl. Bacteriol. 1989, 66, 365–378.
  18. Hill, C.; Guarner, F.; Reid, G.; Gibson, G.R.; Merenstein, D.J.; Pot, B.; Morelli, L.; Canani, R.B.; Flint, H.J.; Salminen, S.; et al. The International Scientific Association for Probiotics and Prebiotics Consensus Statement on the Scope and Appropriate Use of the Term Probiotic. Nat. Rev. Gastroenterol. Hepatol. 2014, 11, 506–514.
  19. Stojanov, S.; Berlec, A.; Štrukelj, B. The Influence of Probiotics on the Firmicutes/Bacteroidetes Ratio in the Treatment of Obesity and Inflammatory Bowel Disease. Microorganisms 2020, 8, 1715.
  20. Rinninella, E.; Raoul, P.; Cintoni, M.; Franceschi, F.; Miggiano, G.A.D.; Gasbarrini, A.; Mele, M.C. What is the Healthy Gut Microbiota Composition? A Changing Ecosystem across Age, Environment, Diet, and Diseases. Microorganisms 2019, 7, 14.
  21. Gilbert, J.; Blaser, M.J.; Caporaso, J.G.; Jansson, J.; Lynch, S.V.; Knight, R. Current Understanding of the Human Microbiome. Nat. Med. 2018, 24, 392–400.
  22. Dekkers, K.F.; Sayols-Baixeras, S.; Baldanzi, G.; Nowak, C.; Hammar, U.; Nguyen, D.; Varotsis, G.; Brunkwall, L.; Nielsen, N.; Eklund, A.C.; et al. An Online Atlas of Human Plasma Metabolite Signatures of Gut Microbiome Composition. Nat Commun. 2022, 13, 5370.
  23. Vijay, A.; Valdes, A.M. Role of the Gut Microbiome in Chronic Diseases: A Narrative Review. Eur. J. Clin. Nutr. 2022, 76, 489–501.
  24. Koblinsky, N.D.; Power, K.A.; Middleton, L.; Ferland, G.; Anderson, N.D. The Role of the Gut Microbiome in Diet and Exercise Effects on Cognition: A Review of the Intervention Literature. J. Gerontol. Ser. A 2022, glac166.
  25. Bruckner, J.J.; Stednitz, S.J.; Grice, M.Z.; Zaidan, D.; Massaquoi, M.S.; Larsch, J.; Tallafuss, A.; Guillemin, K.; Washbourne, P.; Eisen, J.S. The Microbiota Promotes Social Behavior by Modulating Microglial Remodeling of Forebrain Neurons. PLoS Biol. 2022, 20, e3001838.
  26. Veiga, P.; Pons, N.; Agrawal, A.; Oozeer, R.; Guyonnet, D.; Brazeilles, R.; Faurie, J.-M.; Vlieg, J.E.T.v.H.; Houghton, L.A.; Whorwell, P.J.; et al. Changes of the Human Gut Microbiome Induced by a Fermented Milk Product. Sci. Rep. 2014, 4, 6328.
  27. Lisko, D.J.; Johnston, G.P.; Johnston, C.G. Effects of Dietary Yogurt on the Healthy Human Gastrointestinal (GI) Microbiome. Microorganisms 2017, 5, 6.
  28. Le Roy, C.I.; Kurilshikov, A.; Leeming, E.R.; Visconti, A.; Bowyer, R.C.E.; Menni, C.; Falchi, M.; Koutnikova, H.; Veiga, P.; Zhernakova, A.; et al. Yoghurt Consumption is Associated with Changes in the Composition of the Human Gut Microbiome and Metabolome. BMC Microbiol. 2022, 22, 39.
  29. Furman, D.; Campisi, J.; Verdin, E.; Carrera-Bastos, P.; Targ, S.; Franceschi, C.; Ferrucci, L.; Gilroy, D.W.; Fasano, A.; Miller, G.W.; et al. Chronic Inflammation in the Etiology of Disease Across the Life Span. Nat. Med. 2019, 25, 1822–1832.
  30. Warman, D.J.; Jia, H.; Kato, H. The Potential Roles of Probiotics, Resistant Starch, and Resistant Proteins in Ameliorating Inflammation during Aging (Inflammaging). Nutrients 2022, 14, 747.
  31. Villafuerte, K.R.V.; Martinez, C.J.H.; Nobre, A.V.V.; Maia, L.P.; Tirapelli, C. What Are Microbiological Effects of the Adjunctive Use of Probiotics in the Treatment of Periodontal Diseases? A Systematic Review. Benef. Microbes 2021, 12, 307–319.
  32. Song, D.; Lee, H.B.; Kim, G.-B.; Kang, S.-S. Whey Fermented by Enterococcus faecalis M157 Exhibits Antiinflammatory and Antibiofilm Activities Against Oral Pathogenic Bacteria. J. Dairy Sci. 2022, 105, 1900–1912.
  33. Leis, R.; de Castro, M.-J.; de Lamas, C.; Picáns, R.; Couce, M.L. Effects of Prebiotic and Probiotic Supplementation on Lactase Deficiency and Lactose Intolerance: A Systematic Review of Controlled Trials. Nutrients 2020, 12, 1487.
  34. Anbukkarasi, K.; Maheswari, T.U.; Hemalatha, T.; Nanda, D.K.; Singh, P.; Singh, R. Preparation of Low Galactose Yogurt Using Cultures of Gal+ Streptococcus thermophilus in Combination with Lactobacillus delbrueckii ssp. bulgaricus. J. Food Sci. Technol. 2014, 51, 2183–2189.
  35. Chen, L.; Zhou, X.; Wang, Y.; Wang, D.; Ke, Y.; Zeng, X. Propionate and Butyrate Produced by Gut Microbiota after Probiotic Supplementation Attenuate Lung Metastasis of Melanoma Cells in Mice. Mol. Nutr. Food Res. 2021, 65, 2100096.
  36. LeBlanc, J.G.; Milani, C.; de Giori, G.S.; Sesma, F.; van Sinderen, D.; Ventura, M. Bacteria as Vitamin Suppliers to their Host: A Gut Microbiota Perspective. Curr. Opin. Biotechnol. 2013, 24, 160–168.
  37. Diez-Gutiérrez, L.; Vicente, L.S.; Sáenz, J.; Barron, L.J.R.; Chávarri, M. Characterisation of the Probiotic Potential of Lactiplantibacillus plantarum K16 and its Ability to Produce the Postbiotic Metabolite γ-Aminobutyric Acid. J. Funct. Foods 2022, 97, 105230.
  38. Khaneghah, A.M.; Abhari, K.; Eş, I.; Soares, M.B.; Oliveira, R.B.A.; Hosseini, H.; Rezaei, M.; Balthazar, C.F.; Silva, R.; Cruz, A.G.; et al. Interactions between Probiotics and Pathogenic Microorganisms in Hosts and Foods: A Review. Trends Food Sci. Technol. 2020, 95, 205–218.
  39. Ruiz, M.J.; Sirini, N.E.; Signorini, M.L.; Etcheverría, A.; Zbrun, M.V.; Soto, L.P.; Zimmermann, J.A.; Frizzo, L.S. Protective Effect of Lactiplantibacillus plantarum LP5 in a Murine Model of Colonisation by Campylobacter coli DSPV458. Benef. Microbes 2021, 12, 553–565.
  40. Moradi, M.; Mardani, K.; Tajik, H. Characterization and Application of Postbiotics of Lactobacillus spp. on Listeria monocytogenes in vitro and in Food Models. LWT 2019, 111, 457–464.
  41. Silva, D.R.; Sardi, J.d.C.O.; Pitangui, N.d.S.; Roque, S.M.; Barbosa da Silva, A.C.; Rosalen, P.L. Probiotics as an Alternative Antimicrobial Therapy: Current Reality and Future Directions. J. Funct. Foods 2020, 73, 104080.
  42. Beck, L.C.; Masi, A.C.; Young, G.R.; Vatanen, T.; Lamb, C.A.; Smith, R.; Coxhead, J.; Butler, A.; Marsland, B.J.; Embleton, N.D.; et al. Strain-Specific Impacts of Probiotics Are a Significant Driver of Gut Microbiome Development in Very Preterm Infants. Nat. Microbiol. 2022, 7, 1525–1535.
  43. Paytuví-Gallart, A.; Sanseverino, W.; Winger, A.M. Daily Intake of Probiotic Strain Bacillus subtilis DE111 Supports a Healthy Microbiome in Children Attending Day-Care. Benef. Microbes 2020, 11, 611–620.
  44. Black, F.; Einarsson, K.; Lidbeck, A.; Orrhage, K.; Nord, C.E. Effect of Lactic Acid Producing Bacteria on the Human Intestinal Microflora during Ampicillin Treatment. Scand. J. Infect. Dis. 1991, 23, 247–254.
  45. Horvath, A.; Durdevic, M.; Leber, B.; di Vora, K.; Rainer, F.; Krones, E.; Douschan, P.; Spindelboeck, W.; Durchschein, F.; Zollner, G.; et al. Changes in the Intestinal Microbiome during a Multispecies Probiotic Intervention in Compensated Cirrhosis. Nutrients 2020, 12, 1874.
  46. Liu, S.; Liu, H.; Chen, L.; Liang, S.-S.; Shi, K.; Meng, W.; Xue, J.; He, Q.; Jiang, H. Effect of Probiotics on the Intestinal Microbiota of Hemodialysis Patients: A Randomized Trial. Eur. J. Nutr. 2020, 59, 3755–3766.
  47. Almada-Érix, C.N.; Almada, C.N.; Cabral, L.; de Medeiros, V.P.B.; Roquetto, A.R.; Santos-Junior, V.A.; Fontes, M.; Gonçalves, A.E.S.S.; dos Santos, A.; Lollo, P.C.; et al. Orange Juice and Yogurt Carrying Probiotic Bacillus coagulans GBI-30 6086: Impact of Intake on Wistar Male Rats Health Parameters and Gut Bacterial Diversity. Front. Microbiol. 2021, 12, 623951.
  48. Ahmadi, S.; Wang, S.; Nagpal, R.; Wang, B.; Jain, S.; Razazan, A.; Mishra, S.P.; Zhu, X.; Wang, Z.; Kavanagh, K.; et al. A Human-Origin Probiotic Cocktail Ameliorates Aging-Related Leaky Gut and Inflammation Via Modulating the Microbiota/Taurine/Tight Junction Axis. JCI Insight. 2020, 5, e132055.
  49. Popović, N.; Brdarić, E.; Đokić, J.; Dinić, M.; Veljović, K.; Golić, N.; Terzić-Vidojević, A. Yogurt Produced by Novel Natural Starter Cultures Improves Gut Epithelial Barrier In Vitro. Microorganisms 2020, 8, 1586.
  50. Hoffmann, A.; Kleniewska, P.; Pawliczak, R. Antioxidative Activity of Probiotics. Arch. Med. Sci. 2021, 17, 792–804.
  51. Dos Santos Cruz, B.C.; Moraes, L.F.d.S.; Marcon, L.D.N.; Dias, K.A.; Murad, L.B.; Sarandy, M.M.; Lopes da Conceição, L.; Gonçalves, R.V.; Fortes Ferreira, C.L.d.L.; Peluzio, M.d.C.G. Evaluation of the Efficacy of Probiotic VSL#3 and Synbiotic VSL#3 and Yacon-Based Product in Reducing Oxidative Stress and Intestinal Permeability in Mice Induced to Colorectal Carcinogenesis. J. Food Sci. 2021, 86, 1448–1462.
  52. Kostelac, D.; Gerić, M.; Gajski, G.; Frece, J. Probiotic and Paraprobiotic Derivates Exhibit Anti-Inflammatory and Genoprotective Effects during Induced Stress. J. Appl. Microbiol. 2022, 133, 819–829.
  53. Wang, X.; Zhang, P.; Zhang, X. Probiotics Regulate Gut Microbiota: An Effective Method to Improve Immunity. Molecules 2021, 26, 6076.
  54. Rajoka, M.S.R.; Wu, Y.; Mehwish, H.M.; Bansal, M.; Zhao, L. Lactobacillus Exopolysaccharides: New Perspectives on Engineering Strategies, Physiochemical Functions, and Immunomodulatory Effects on Host Health. Trends Food Sci. Technol. 2020, 103, 36–48.
  55. Smecuol, E.; Constante, M.; Temprano, M.P.; Costa, A.F.; Moreno, M.L.; Pinto-Sanchez, M.I.; Vázquez, H.; Stefanolo, J.P.; Gonzalez, A.F.; D’Adamo, C.R.; et al. Effect of Bifidobacterium infantis NLS Super Strain in Symptomatic Coeliac Disease Patients on Long-Term Gluten-Free Diet—An Exploratory Study. Benef. Microbes. 2020, 11, 527–534.
  56. Kanauchi, O.; Andoh, A.; Bakar, S.A.; Yamamoto, N. Probiotics and Paraprobiotics in Viral Infection: Clinical Application and Effects on the Innate and Acquired Immune Systems. Curr. Pharmac. Des. 2018, 24, 710–717.
  57. Petrova, M.I.; van den Broek, M.F.L.; Spacova, I.; Verhoeven, T.L.A.; Balzarini, J.; Vanderleyden, J.; Schols, D.; Lebeer, S. Engineering Lactobacillus rhamnosus GG and GR-1 to Express HIV-Inhibiting Griffithsin. Int. J. Antimicrob. Agents 2018, 52, 599–607.
  58. Anukam, K.C.; Osazuwa, E.O.; Osadolor, H.B.; Bruce, A.W.; Reid, G. Yogurt Containing Probiotic Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 Helps Resolve Moderate Diarrhea and Increases CD4 Count in HIV/AIDS Patients. J. Clin. Gastroenterol. 2008, 42, 239–243.
  59. Xu, B.; Liang, S.; Zhao, J.; Li, X.; Guo, J.; Xin, B.; Li, B.; Huo, G.; Ma, W. Bifidobacterium animalis subsp. lactis XLTG11 Improves Antibiotic-Related Diarrhea by Alleviating Inflammation, Enhancing Intestinal Barrier Function and Regulating Intestinal Flora. Food Funct. 2022, 13, 6404–6418.
  60. Tian, Y.; Li, M.; Song, W.; Jiang, R.; Li, Y.Q. Effects of Probiotics on Chemotherapy in Patients with Lung Cancer. Oncol. Lett. 2019, 17, 2836–2848.
  61. Whelan, K. Enteral-Tube-Feeding Diarrhoea: Manipulating the Colonic Microbiota with Probiotics and Prebiotics. Proc. Nutr. Soc. 2007, 66, 299–306.
  62. Yang, Y.; Pei, J.; Qin, Z.; Wei, L. Efficacy of Probiotics to Prevent and/or Alleviate Childhood Rotavirus Infections. J. Funct. Foods 2019, 52, 90–99.
  63. Sazawal, S.; Hiremath, G.; Dhingra, U.; Malik, P.; Deb, S.; Black, R.E. Efficacy of Probiotics in Prevention of Acute Diarrhoea: A Meta-Analysis of Masked, Randomised, Placebo-Controlled Trials. Lancet Infect. Dis. 2006, 6, 374–382.
  64. Hilton, E.; Kolakowski, P.; Singer, C.; Smith, M. Efficacy of Lactobacillus GG as a Diarrheal Preventive in Travelers. J. Travel Med. 1997, 4, 41–43.
  65. Black, F.T.; Andersen, P.L.; Ørskov, J.; Ørskov, F.; Gaarslev, K.; Laulund, S. Prophylactic Efficacy of Lactobacilli on Traveler’s Diarrhea. In Travel Medicine; Steffan, R., Lobel, H., Haworth, J., Bradley, D.J., Eds.; Springer: Berlin/Heidelberg, Germany, 1989.
  66. Wu, Z.; Xu, Q.; Gu, S.; Wang, Q.; Chen, Y.; Lv, L.; Zheng, B.; Wang, K.; Wang, S.; Xia, J.; et al. Modulation of Lactobacillus rhamnosus GG on the Gut Microbiota and Metabolism in Mice with Clostridioides difficile Infection. Food Funct. 2022, 13, 5667–5679.
  67. Parra-Sepúlveda, C.; Sánchez-Alonzo, K.; Olivares-Muñoz, J.; Gutiérrez-Zamorano, C.; Smith, C.T.; Carvajal, R.I.; Sáez-Carrillo, K.; González, C.; García-Cancino, A. Consumption of a Gelatin Supplemented with the Probiotic Strain Limosilactobacillus fermentum UCO-979C Prevents Helicobacter pylori Infection in a Young Adult Population Achieved. Foods 2022, 11, 1668.
  68. He, Y.; Zhu, L.; Chen, J.; Tang, X.; Pan, M.; Yuan, W.; Wang, H. Efficacy of Probiotic Compounds in Relieving Constipation and their Colonization in Gut Microbiota. Molecules 2022, 27, 666.
  69. Chen, J.L.; Zhang, W.X.; Gan, D. Alleviation of Slow Transit Constipation by Probiotics Complex. Food Ferment. Inds. 2022, 48, 95–100.
  70. Van der Geest, A.M.; Schukking, I.; Brummer, R.J.M.; van de Burgwal, L.H.M.; Larsen, O.F.A. Comparing Probiotic and Drug Interventions in Irritable Bowel Syndrome: A Meta-Analysis of Randomised Controlled Trials. Benef. Microbes 2022, 13, 183–194.
  71. Tobias, J.; Olyaei, A.; Laraway, B.; Jordan, B.K.; Dickinson, S.L.; Golzarri-Arroyo, L.; Fialkowski, E.; Owora, A.; Scottoline, B. Bifidobacterium longum subsp. infantis EVC001 Administration is Associated with a Significant Reduction in the Incidence of Necrotizing Enterocolitis in Very Low Birth Weight Infants. J. Pediatr. 2022, 244, 64–71.
  72. Dong, J.; Teng, G.; Wei, T.; Gao, W.; Wang, H. Methodological Quality Assessment of Meta-Analyses and Systematic Reviews of Probiotics in Inflammatory Bowel Disease and Pouchitis. PLoS ONE 2016, 11, e0168785.
  73. LeBlanc, J.-F.; Segal, J.P.; de Campos Braz, L.M.; Hart, A.L. The Microbiome as a Therapy in Pouchitis and Ulcerative Colitis. Nutrients 2021, 13, 1780.
  74. Wan, Y.D.; Zhu, R.X.; Bian, Z.Z.; Sun, T.W. Effect of Probiotics on Length of Hospitalization in Mild Acute Pancreatitis: A Randomized, Double-Blind, Placebo-Controlled Trial. World J. Gastroenterol. 2021, 27, 224–232.
  75. Tang, G.; Zhang, L. Update on Strategies of Probiotics for the Prevention and Treatment of Colorectal Cancer. Nutr. Cancer 2022, 74, 27–38.
  76. Davoodvandi, A.; Fallahi, F.; Tamtaji, O.R.; Tajiknia, V.; Banikazemi, Z.; Fathizadeh, H.; Abbasi-Kolli, M.; Aschner, M.; Ghandali, M.; Sahebkar, A.; et al. An Update on the Effects of Probiotics on Gastrointestinal Cancers. Front. Pharmacol. 2021, 12, 680400.
  77. Srikham, K.; Daengprok, W.; Niamsup, P.; Thirabunyanon, M. Characterization of Streptococcus salivarius as New Probiotics Derived from Human Breast Milk and their Potential on Proliferative Inhibition of Liver and Breast Cancer Cells and Antioxidant Activity. Front. Microbiol. 2021, 12, 797445.
  78. Ranjbar, S.; Seyednejad, S.A.; Azimi, H.; Rezaeizadeh, H.; Rahimi, R. Emerging Roles of Probiotics in Prevention and Treatment of Breast Cancer: A Comprehensive Review of their Therapeutic Potential. Nutr. Cancer 2019, 71, 1–12.
  79. Wu, H.; Ganguly, S.; Tollefsbol, T.O. Modulating Microbiota as a New Strategy for Breast Cancer Prevention and Treatment. Microorganisms 2022, 10, 1727.
  80. Rosa, L.S.; Santos, M.L.; Abreu, J.P.; Balthazar, C.F.; Rocha, R.S.; Silva, H.L.A.; Esmerino, E.A.; Duarte, M.C.K.H.; Pimentel, T.C.; Freitas, M.Q.; et al. Antiproliferative and Apoptotic Effects of Probiotic Whey Dairy Beverages in Human Prostate Cell Lines. Food Res. Int. 2020, 137, 109450.
  81. Kandati, K.; Belagal, P.; Nannepaga, J.S.; Viswanath, B. Role of Probiotics in the Management of Cervical Cancer: An Update. Clin. Nutr. ESPEN 2022, 48, 5–16.
  82. Yurtdaş, G.; Akdevelioğlu, Y. A New Approach to Polycystic Ovary Syndrome: The Gut Microbiota. J. Am. Coll. Nutr. 2020, 39, 371–382.
  83. Qian, Z.; Zhu, H.; Zhao, D.; Yang, P.; Gao, F.; Lu, C.; Yin, Y.; Kan, S.; Chen, D. Probiotic Lactobacillus sp. Strains Inhibit Growth, Adhesion, Biofilm Formation, and Gene Expression of Bacterial Vaginosis-Inducing Gardnerella vaginalis. Microorganisms 2021, 9, 728.
  84. Aburjaile, F.F.; Viana, M.V.C.; Cerqueira, J.C.; de Jesus, L.C.L.; da Silva, T.F.; Carvalho, R.; Azevedo, V. Probiotic Potential of Novel Brazilian Lactobacillus crispatus Strains. Genet. Mol. Res. 2021, 20, 18900.
  85. Li, P.; Wei, K.; He, X.; Zhang, L.; Liu, Z.; Wei, J.; Chen, X.; Wei, H.; Chen, T. Vaginal Probiotic Lactobacillus crispatus Seems to Inhibit Sperm Activity and Subsequently Reduces Pregnancies in Rat. Front. Cell Dev. Biol. 2021, 9, 705690.
  86. Wang, Y.; Xie, Z. Exploring the Role of Gut Microbiome in Male Reproduction. Andrology 2022, 10, 441–450.
  87. Feyisetan, O.; Tracey, C.; Hellawell, G.O. Probiotics, Dendritic Cells and Bladder Cancer. BJU Int. 2011, 109, 1594–1597.
  88. Zoqlam, R.; Lazauskaite, S.; Glickman, S.; Zaitseva, L.; Ilie, P.-C.; Qi, S. Emerging Molecular Mechanisms and Genetic Targets for Developing Novel Therapeutic Strategies for Treating Bladder Diseases. Eur. J. Pharm Sci. 2022, 173, 106167.
  89. Sadeghi-bojd, S.; Naghshizadian, R.; Mazaheri, M.; Sharbaf, F.G.; Assadi, F. Efficacy of Probiotic Prophylaxis after the First Febrile Urinary Tract Infection in Children with Normal Urinary Tracts. J. Pediatric Infect. Dis. Soc. 2020, 9, 305–310.
  90. Campieri, C.; Campieri, M.; Bertuzzi, V.; Swennen, E.; Matteuzzi, D.; Stefoni, S.; Pirovano, F.; Centi, C.; Ulisse, S.; Famularo, G.; et al. Reduction of Oxaluria after an Oral Course of Lactic Acid Bacteria at High Concentration. Kidney Int. 2001, 60, 1097–1105.
  91. Yamaguchi, T.; Tsuji, S.; Akagawa, S.; Akagawa, Y.; Kino, J.; Yamanouchi, S.; Kimata, T.; Hashiyada, M.; Akane, A.; Kaneko, K. Clinical Significance of Probiotics for Children with Idiopathic Nephrotic Syndrome. Nutrients 2021, 13, 365.
  92. Picó-Monllor, J.A.; Ruzafa-Costas, B.; Núñez-Delegido, E.; Sánchez-Pellicer, P.; Peris-Berraco, J.; Navarro-Lopez, V. Selection of Probiotics in the Prevention of Respiratory Tract Infections and their Impact on Occupational Health: Scoping Review. Nutrients 2021, 13, 4419.
  93. Lu, W.; Fang, Z.; Liu, X.; Li, L.; Zhang, P.; Zhao, J.; Zhang, H.; Chen, W. The Potential Role of Probiotics in Protection Against Influenza a Virus Infection in Mice. Foods 2021, 10, 902.
  94. Nguyen, Q.V.; Chong, L.C.; Hor, Y.-Y.; Lew, L.-C.; Rather, I.A.; Choi, S.-B. Role of Probiotics in the Management of COVID-19: A Computational Perspective. Nutrients 2022, 14, 274.
  95. Manzanares, W.; Lemieux, M.; Langlois, P.L.; Wischmeyer, P.E. Probiotic and Synbiotic Therapy in Critical Illness: A Systematic Review and Meta-Analysis. Crit. Care 2016, 20, 262.
  96. Yamanishi, S.; Pawankar, R. Current Advances on the Microbiome and Role of Probiotics in Upper Airways Disease. Curr. Opin. Allergy Clin. Immunol. 2020, 20, 30–35.
  97. Velez, E.; Novotny-Nuñez, I.; Correa, S.; Perdigón, G.; Maldonado-Galdeano, C. Modulation of Gut Immune Response by Probiotic Fermented Milk Consumption to Control IgE in a Respiratory Allergy Model. Benef. Microbes 2021, 12, 175–186.
  98. Chen, C.-M.; Cheng, S.-H.; Chen, Y.-H.; Wu, C.-C.; Hsu, C.-C.; Lin, C.-T.; Tsai, Y.-C. Supplementation with Heat-Inactivated Lacticaseibacillus paracasei K47 Ameliorates Allergic Asthma in Mice by Regulating the Th1/Th2 Balance. Benef. Microbes 2022, 13, 73–82.
  99. Van Dorst, J.M.; Tam, R.Y.; Ooi, C.Y. What Do We Know About the Microbiome in Cystic Fibrosis? Is There a Role for Probiotics and Prebiotics? Nutrients 2022, 14, 480.
  100. Fang, Z.; Li, L.; Zhang, H.; Zhao, J.; Lu, W.; Chen, W. Gut Microbiota, Probiotics, and their Interactions in Prevention and Treatment of Atopic Dermatitis: A Review. Front. Immunol. 2021, 12, 720393.
  101. Szántó, M.; Dózsa, A.; Antal, D.; Szabó, K.; Kemény, L.; Bai, P. Targeting the Gut-Skin Axis—Probiotics as New Tools for Skin Disorder Management? Exp. Dermatol. 2019, 28, 1210–1218.
  102. Levkovich, T.; Poutahidis, T.; Smillie, C.; Varian, B.J.; Ibrahim, Y.M.; Lakritz, J.R.; Alm, E.J.; Erdman, S.E. Probiotic Bacteria Induce a ‘Glow of Health’. PLoS ONE 2013, 8, e53867.
  103. Yun, S.-W.; Son, Y.-H.; Lee, D.-Y.; Shin, Y.-J.; Han, M.J.; Kim, D.-H. Lactobacillus plantarum and Bifidobacterium bifidum Alleviate Dry Eye in Mice with Exorbital Lacrimal Gland Excision by Modulating Gut Inflammation and Microbiota. Food Funct. 2021, 12, 2489.
  104. Iovieno, A.; Lambiase, A.; Sacchetti, M.; Stampachiacchiere, B.; Micera, A.; Bonini, S. Preliminary Evidence of the Efficacy of Probiotic Eye-Drop Treatment in Patients with Vernal Keratoconjunctivitis. Graefes Arch. Clin. Exp. Ophthalmol. 2008, 246, 435–441.
  105. Bungau, S.G.; Behl, T.; Singh, A.; Sehgal, A.; Singh, S.; Chigurupati, S.; Vijayabalan, S.; Das, S.; Palanimuthu, V.R. Targeting Probiotics in Rheumatoid Arthritis. Nutrients 2021, 13, 3376.
  106. Sanchez, P.; Letarouilly, J.-G.; Nguyen, Y.; Sigaux, J.; Barnetche, T.; Czernichow, S.; Flipo, R.-M.; Sellam, J.; Daïen, C. Efficacy of Probiotics in Rheumatoid Arthritis and Spondyloarthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrients 2022, 14, 354.
  107. Lei, M.; Hua, L.-M.; Wang, D.-W. The Effect of Probiotic Treatment on Elderly Patients with Distal Radius Fracture: A Prospective Double-Blind, Placebo-Controlled Randomised Clinical Trial. Benef. Microbes 2016, 7, 631–637.
  108. Lei, M.; Guo, C.; Wang, Y.; Hua, L.; Xue, S.; Yu, D.; Zhang, C.; Wang, D. Oral Administration of Probiotic Lactobacillus casei Shirota Relieves Pain after Single Rib Fracture: A Randomized Double-Blind, Placebo-Controlled Clinical Trial. Asia Pac. J. Clin. Nutr. 2018, 27, 1252–1257.
  109. Kruger, M.C.; Fear, A.; Chua, W.-H.; Plimmer, G.G.; Schollum, L.M. The Effect of Lactobacillus rhamnosus HN001 on Mineral Absorption and Bone Health in Growing Male and Ovariectomised Female Rats. Dairy Sci. Technol. 2009, 89, 219–231.
  110. Cornes, R.; Sintes, C.; Peña, A.; Albin, S.; O’Brien, K.O.; Abrams, S.A.; Donangelo, C.M. Daily Intake of a Functional Synbiotic Yogurt Increases Calcium Absorption in Young Adult Women. J. Nutr. 2022, 152, 1647–1654.
  111. Vonderheid, S.C.; Tussing-Humphreys, L.; Park, C.; Pauls, H.; OjiNjideka Hemphill, N.; LaBomascus, B.; McLeod, A.; Koenig, M.D. A Systematic Review and Meta-Analysis on the Effects of Probiotic Species on Iron Absorption and Iron Status. Nutrients 2019, 11, 2938.
  112. Trotter, R.E.; Vazquez, A.R.; Grubb, D.S.; Freedman, K.E.; Grabos, L.E.; Jones, S.; Gentile, C.L.; Melby, C.L.; Johnson, S.A.; Weir, T.L. Bacillus subtilis DE111 Intake May Improve Blood Lipids and Endothelial Function in Healthy Adults. Benef. Microbes 2020, 11, 621–630.
  113. Zhang, C.; Jiang, J.; Wang, C.; Li, S.; Yu, L.; Tian, F.; Zhao, J.; Zhang, H.; Chen, W.; Zhai, Q. Meta-Analysis of Randomized Controlled Trials of the Effects of Probiotics on Type 2 Diabetes in Adults. Clin. Nutr. 2022, 41, 365–373.
  114. Bayat, A.; Azizi-Soleiman, F.; Heidari-Beni, M.; Feizi, A.; Iraj, B.; Ghiasvand, R.; Askari, G. Effect of Cucurbita ficifolia and Probiotic Yogurt Consumption on Blood Glucose, Lipid Profile, and Inflammatory Marker in Type 2 Diabetes. Int. J. Prev. Med. 2016, 7, 30.
  115. O’Morain, V.L.; Ramji, D.P. The Potential of Probiotics in the Prevention and Treatment of Atherosclerosis. Mol. Nutr. Food Res. 2020, 64, 1900797.
  116. Maldonado-Lobón, J.A.; Blanco-Rojo, R.; Maldonado, J.; Ali, M.A.; Almazán, M.V.; Suanes-Cabello, A.; Callejón, E.; Jaldo, R.; Benavídes, M.R.; Negrillo, A.M.; et al. Efficacy of Bifidobacterium breve CECT7263 for Infantile Colic Treatment: An Open-Label, Parallel, Randomised, Controlled Trial. Benef. Microbes 2021, 12, 55–67.
  117. Poutahidis, T.; Kleinewietfeld, M.; Smillie, C.; Levkovich, T.; Perrotta, A.; Bhela, S.; Varian, B.J.; Ibrahim, Y.M.; Lakritz, J.R.; Kearney, S.M.; et al. Microbial Reprogramming Inhibits Western Diet-Associated Obesity. PLoS ONE 2013, 8, e68596.
  118. Tomé-Castro, X.M.; Rodriguez-Arrastia, M.; Cardona, D.; Rueda-Ruzafa, L.; Molina-Torres, G.; Roman, P. Probiotics as a Therapeutic Strategy in Obesity and Overweight: A Systematic Review. Benef. Microbes 2021, 12, 5–15.
  119. Jantararussamee, C.; Rodniem, S.; Taweechotipatr, M.; Showpittapornchai, U.; Pradidarcheep, W. Hepatoprotective Effect of Probiotic Lactic Acid Bacteria on Thioacetamide-Induced Liver Fibrosis in Rats. Probiotics Antimicrob. Proteins 2021, 13, 40–50.
  120. Jin, H.; Xu, X.; Pang, B.; Yang, R.; Sun, H.; Jiang, C.; Shao, D.; Shi, J. Probiotic and Prebiotic Interventions for Non-Alcoholic Fatty Liver Disease: A Systematic Review and Network Meta-Analysis. Benef. Microbes 2021, 12, 517–529.
  121. Zhao, H.; Lu, Z.; Lu, Y. The Potential of Probiotics in the Amelioration of Hyperuricemia. Food Funct. 2022, 13, 2394.
  122. De Oliveira Filho, J.G.; Carvalho, A.S.e.S.; Alves, J.D.S.; Egea, M.B. Next-Generation Probiotics as a Therapeutic Strategy for the Treatment of Phenylketonuria: A Review. Nut. Rev. 2022, 80, 2100–2112.
  123. Lee, M.-C.; Hsu, Y.-J.; Ho, H.-H.; Hsieh, S.-H.; Kuo, Y.-W.; Sung, H.-C.; Huang, C.-C. Lactobacillus salivarius subspecies salicinius SA-03 is a New Probiotic Capable of Enhancing Exercise Performance and Decreasing Fatigue. Microorganisms 2020, 8, 545.
  124. Haarhuis, J.E.; Kardinaal, A.; Kortman, G.A.M. Probiotics, Prebiotics and Postbiotics for Better Sleep Quality: A Narrative Review. Benef. Microbes 2022, 13, 169–182.
  125. Ansari, F.; Pourjafar, H.; Tabrizi, A.; Homayouni, A. The Effects of Probiotics and Prebiotics on Mental Disorders: A Review on Depression, Anxiety, Alzheimer, and Autism Spectrum Disorders. Current Pharma. Biotechnol. 2020, 21, 555–565.
  126. Rao, A.V.; Bested, A.C.; Beaulne, T.M.; Katzman, M.A.; Iorio, C.; Berardi, J.M.; Logan, A.C. A Randomized, Double-Blind, Placebo-Controlled Pilot Study of a Probiotic in Emotional Symptoms of Chronic Fatigue Syndrome. Gut Pathog. 2009, 1, 6.
  127. Jeong, J.; Lee, Y.; Yoon, S.; Kim, J.-H.; Kim, W. Lactiplantibacillus plantarum LRCC5314 Includes a Gene for Serotonin Biosynthesis Via the Tryptophan Metabolic Pathway. J. Microbiol. 2021, 59, 1092–1103.
  128. Benton, D.; Williams, C.; Brown, A. Impact of Consuming a Milk Drink Containing a Probiotic on Mood and Cognition. Eur. J. Clin. Nutr. 2007, 61, 355–361.
  129. Ho, S.-T.; Hsieh, Y.-T.; Wang, S.-Y.; Chen, M.-J. Improving Effect of a Probiotic Mixture on Memory and Learning Abilities in D-Galactose-Treated Aging Mice. J. Dairy Sci. 2019, 102, 1901–1909.
  130. Meng, H.Y.H.; Mak, C.C.H.; Mak, W.Y.; Zuo, T.; Ko, H.; Chan, F.K.L. Probiotic Supplementation Demonstrates Therapeutic Potential in Treating Gut Dysbiosis and Improving Neurocognitive Function in Age-Related Dementia. Eur. J. Nutr. 2022, 61, 1701–1734.
  131. Song, W.; Zhang, M.; Teng, L.; Wang, Y.; Zhu, L. Prebiotics and Probiotics for Autism Spectrum Disorder: A Systematic Review and Meta-Analysis of Controlled Clinical Trials. J. Med. Microbiol. 2022, 71, 001510.
  132. Azevedo, K.P.; de Jesus Catulio, M.Z.; de Souza, R.G.M.; Stringhini, M.L.F. Probiotics in Crohn’s Disease Remission: A Systematic Review. Arch. Latinoam. Nutr. 2022, 72, 50–59.
  133. Sakandar, H.A.; Zhang, H. Trends in Probiotic(s)—Fermented Milks and Their in vivo Functionality: A Review. Trends Food Sci. Tech. 2021, 110, 55–65.
  134. Hadjimbei, E.; Botsaris, G.; Chrysostomou, S. Beneficial Effects of Yoghurts and Probiotic Fermented Milks and Their Functional Food Potential. Foods 2022, 11, 2691.
  135. Fantinato, V.; de Carvalho, H.R.; de Sousa, A.L.O.P. Use of Yogurt Prepared with the Probiotic Streptococcus salivarius BIO5 Strain in the Control of Bacterial Tonsillitis in Children. Int. J. Probiotics Prebiotics 2020, 15, 30–33.
  136. Ng, S.C.; Hart, A.L.; Kamm, M.A.; Stagg, A.J.; Knight, S.C. Mechanisms of Action of Probiotics: Recent Advances. Inflamm. Bowel Dis. 2009, 15, 300–310.
  137. Sánchez, B.; Delgado, S.; Blanco-Miguez, A.; Lourenço, A.; Gueimonde, M.; Margolles, A. Probiotics, Gut Microbiota, and Their Influence on Host Health and Disease. Mol. Nutr. Food Res. 2017, 61, 1600240.
  138. Mathipa-Mdakane, M.G.; Thantsha, M.S. Lacticaseibacillus rhamnosus: A Suitable Candidate for the Construction of Novel Bioengineered Probiotic Strains for Targeted Pathogen Control. Foods 2022, 11, 785.
  139. Zhang, C.; Derrien, M.; Levenez, F.; Brazeilles, R.; Ballal, S.A.; Kim, J.; Degivry, M.-C.; Quéré, G.; Garault, P.; van Hylckama Vlieg, J.E.T.; et al. Ecological Robustness of the Gut Microbiota in Response to Ingestion of Transient Food-Borne Microbes. ISME J. 2016, 10, 2235–2245.
  140. Veiga, P.; Suez, J.; Derrien, M.; Elinav, E. Moving from Probiotics to Precision Probiotics. Nat. Microbiol. 2020, 5, 878–880.
  141. Pannell, L.K.; Merkwae, L. Bite Sized Refrigerated Yogurt Products. U.S. Patent 20110287147, 24 November 2011.
  142. Yang, G.; Elegbede, J.; Prodduk, V. Snack Bars and Methods of Making. U.S. Patent 11324241, 26 September 2019.
  143. Dwivedi, B.K. Fruit Snack with Probiotics and Method of Manufacturing a Fruit Snack with Probiotics. U.S. Patent 11317640, 3 May 2022.
  144. Gutknecht, J.R.; Ovitt, J.B. Yogurt-Cheese Compositions. U.S. Patent 8486476, 16 July 2013.
  145. Bauer, A.M.; Sambor, B. Food Products Containing Powdered Yogurt, Whole Grains and Fruit. U.S. Patent 20140287126, 25 September 2014.
  146. Diermeier, D.J.; Faa, P.; Wilson, E. Yogurt Crisp and Method for Making Same. U.S. Patent 20190029312, 31 January 2019.
  147. Atwaa, E.S.H.; Shahein, M.R.; El-Sattar, E.S.A.; Hijazy, H.H.A.; Albrakati, A.; Elmahallawy, E.K. Bioactivity, Physicochemical and Sensory Properties of Probiotic Yoghurt Made from Whole Milk Powder Reconstituted in Aqueous Fennel Extract. Fermentation 2022, 8, 52.
  148. Mousavi, M.; Heshmati, A.; Garmakhany, A.D.; Vahidinia, A.; Taheri, M. Optimization of the Viability of Lactobacillus acidophilus and Physico-Chemical, Textural and Sensorial Characteristics of Flaxseed-Enriched Stirred Probiotic Yogurt by Using Response Surface Methodology. LWT 2019, 102, 80–88.
  149. Arab, R.; Freidja, M.L.; Oomah, B.D.; Benali, S.; Madani, K.; Boulekbache-Makhlouf, L. Quality Parameters, Probiotic Viability and Sensory Properties of Probiotic Stirred Sesame Yogurt. Ann. Univ. Dunarea De Jos Galati Fascicle VI Food Technol. 2020, 44, 9–25.
  150. Katke, S.D.; Deshpande, H.W. Studies on Development of Fibre Rich Probiotic Frozen Yogurt. Asian J. Dairy Food Res. 2022, 41, 142–149.
  151. Ibrahim, M.; Barakova, N.; Jõudu, I. Enrichment of the Low-Fat Yoghurt with Oat β-Glucan and EPS-Producing Bifidobacterium bifidum Improves its Quality. Agron. Res. 2020, 18, 1689–1699.
  152. Gunenc, A.; Alswiti, C.; Hosseinian, F. Wheat Bran Dietary Fiber: Promising Source of Prebiotics with Antioxidant Potential. J. Food Res. 2017, 6, 1.
  153. He, J.; Han, Y.; Liu, M.; Wang, Y.; Yang, Y.; Yang, X. Effect of 2 Types of Resistant Starches on the Quality of Yogurt. J. Dairy Sci. 2019, 102, 3956–3964.
  154. Sidhu, M.K.; Lyu, F.; Sharkie, T.P.; Ajlouni, S.; Ranadheera, C.S. Probiotic Yogurt Fortified with Chickpea Flour: Physico-Chemical Properties and Probiotic Survival during Storage and Simulated Gastrointestinal Transit. Foods 2020, 9, 1144.
  155. Aryana, K.J.; Plauche, S.; Nia, T. Prebiotic and Probiotic Fat Free Yogurt. Milchwissenschaft 2007, 62, 295–298.
  156. Erkaya-Kotan, T. In Vitro Angiotensin Converting Enzyme (ACE)-Inhibitory and Antioxidant Activity of Probiotic Yogurt Incorporated with Orange Fibre during Storage. J. Food Sci. Technol. 2020, 57, 2343–2353.
  157. Sendra, E.; Fayos, P.; Lario, Y.; Fernández-López, J.; Sayas-Barberá, E.; Pérez-Alvarez, J.A. Incorporation of Citrus Fibers in Fermented Milk Containing Probiotic Bacteria. Food Microbiol. 2008, 25, 13–21.
  158. Fan, X.; Shi, Z.; Xu, J.; Li, C.; Li, X.; Jiang, X.; Du, L.; Tu, M.; Zeng, X.; Wu, Z.; et al. Characterization of the Effects of Binary Probiotics and Wolfberry Dietary Fiber on the Quality of Yogurt. Food Chem. 2023, 406, 135020.
  159. Atik, D.S.; Coşkun, F. Some Properties of Probiotic Yoghurt Produced for Babies by Adding Fruit Puree, Containing B. infantis, B. bifidum, B. longum, L. paracasei. Turkish J. Agr. Food Sci. Technol. 2021, 9, 1840–1848.
  160. Sun, X.; Wang, Y.R.; Ding, R.X.; Ming, L.Y.; Yue, X.Q.; Wu, J.R. Development of Probiotic Dragon Fruit Yogurt. Food Res. Dev. 2018, 39, 99–103.
  161. Silva, F.A.; Queiroga, R.d.C.R.d.E.; de Souza, E.L.; Voss, G.B.; Borges, G.d.S.C.; Lima, M.d.S.; Pintado, M.M.E.; Vasconcelos, M.A.d.S. Incorporation of Phenolic-Rich Ingredients from Integral Valorization of Isabel Grape Improves the Nutritional, Functional, and Sensory Characteristics of Probiotic Goat Milk Yogurt. Food Chem. 2022, 369, 130957.
  162. Muchiri, M.N.; McCartney, A.L.; Methven, L. Sensory Profile and Consumer Preference of Novel Probiotic Yoghurt Enriched with Orange Sweet Potato (Ipomoea batatas). Afr. J. Food Agric. Nutr. Dev. 2020, 20, 16471–16489.
  163. Ertem, H.; Çakmakçi, S. Shelf Life and Quality of Probiotic Yogurt Produced with Lactobacillus acidophilus and Gobdin. Int. J. Food Sci. Technol. 2018, 53, 776–783.
  164. Al-Aswad, S.; Helal, A.; Shamsia, S.M.; Awad, S. Quality and Rheological Properties of Sweetened Yoghurt and Bio-Yoghurt Enriched with Pomegranate Juice. Egyptian J. Dairy Sci. 2018, 46, 41–50.
  165. Cliff, M.A.; Fan, L.; Sanford, K.; Stanich, K.; Doucette, C.; Raymond, N. Descriptive Analysis and Early-Stage Consumer Acceptance of Yogurts Fermented with Carrot Juices. J. Dairy Sci. 2013, 96, 4160–4172.
  166. Song, H.; Ma, L.H.; Chen, X.H.; Lyu, Q.; Gu, Y. Study on Technology and Inoxidability of Complex Probiotics Yogurt of Kiwi Fruit and Jasmine Flower. China Dairy Ind. 2017, 45, 61–64.
  167. Illupapalayam, V.V.; Smith, S.C.; Gamlath, S. Consumer Acceptability and Antioxidant Potential of Probiotic-Yogurt with Spices. LWT 2014, 55, 255–262.
  168. Yangilar, F.; Yildiz, P.O. Effects of Using Combined Essential Oils on Quality Parameters of Bio-Yogurt. J. Food Process. Preserv. 2018, 42, e13332.
  169. Mehdizadeh, T.; Langroodi, A.M.; Shakouri, R.; Khorshidi, S. Physicochemical, Microbiological, and Sensory Characteristics of Probiotic Yogurt Enhanced with Anethum graveolens essential oil. J. Food Saf. 2019, 39, e12683.
  170. Azizkhani, M.; Parsaeimehr, M. Probiotics Survival, Antioxidant Activity and Sensory Properties of Yogurt Flavored with Herbal Essential Oils. Int. Food Res. J. 2018, 25, 921–927.
  171. Coskun, F.; Dirican, L.K. Effects of Pine Honey on the Physicochemical, Microbiological and Sensory Properties of Probiotic Yoghurt. Food Sci. Technol Camp. 2019, 39 (Suppl. 2), 616–625.
  172. Kavas, N. Functional Probiotic Yoghurt Production with Royal Jelly Fortification and Determination of Some Properties. Int. J. Gastron. Food Sci. 2022, 28, 100519.
  173. Narayana, R.; Kale, A. Functional Probiotic Yoghurt with Spirulina. Asian J. Dairy Food Res. 2019, 38, 311–314.
More
© Text is available under the terms and conditions of the Creative Commons Attribution (CC BY) license; additional terms may apply. By using this site, you agree to the Terms and Conditions and Privacy Policy.
Upload a video for this entry
Information
Subjects: Food Science & Technology; Agriculture, Dairy & Animal Science; Microbiology
Contributors MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register :
Douglas W. Olson
,
Kayanush J. Aryana
View Times: 680
Entry Collection: Gastrointestinal Disease
Revisions: 2 times (View History)
Update Date: 21 Dec 2022
Table of Contents
    1000/1000
    Hot Most Recent
    ScholarVision Creations
    Feedback